Brilinta and Glucovance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Brilinta (ticagrelor) and Glucovance (glyburide; metformin hydrochloride). Common drug interactions include coronary artery occlusion among females and dizziness among males.

The phase IV clinical study analyzes what interactions people have when they take Brilinta and Glucovance. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

What is Glucovance?

Glucovance has active ingredients of glyburide; metformin hydrochloride. It is often used in diabetes. eHealthMe is studying from 6,302 Glucovance users. Check the latest studies of Glucovance.

On Jul, 12, 2026

11 people who take Brilinta and Glucovance together, and have interactions are studied.

Brilinta and Glucovance drug interactions.

What are the common drug interactions of Brilinta and Glucovance, by gender? *:

female:

Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
Cardiac disorder
Dry skin
Pain
Pruritus generalised (generalized itching)

male:

Dizziness
Fatigue (feeling of tiredness)
Blood iron decreased
Chronic kidney disease
Device occlusion
Drug ineffective
Dyspnoea (difficult or laboured respiration)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Eosinophil count increased
Epistaxis (bleed from the nose)

What are the common drug interactions of Brilinta and Glucovance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Pain

60+:

Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
Hypertension (high blood pressure)
Device occlusion
Drug ineffective
Dry skin
Dyspnoea (difficult or laboured respiration)
Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
Epistaxis (bleed from the nose)
Gastritis (inflammation of stomach)
Haemoglobin decreased

What are the existing conditions these people have? *

High Blood Pressure: 3 people, 27.27%
Heart Attack: 3 people, 27.27%
Cardiac Disorder: 2 people, 18.18%
Chest Pain: 2 people, 18.18%
Depression: 2 people, 18.18%
Type 2 Diabetes: 2 people, 18.18%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 9.09%
Dyspnea (difficult or laboured breathing): 1 person, 9.09%
Angina Unstable (chest pain due to ischemia of the heart muscle- unstable): 1 person, 9.09%
Arterial Occlusive Disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Brilinta and Glucovance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously